Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × tazemetostat × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Follicular 10 Sarcoma 5 Lymphoma, Non-Hodgkin 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Prostatic Neoplasms 3 Sarcoma, Synovial 2 Rhabdoid Tumor 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Lymphoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Tertiary Lymphoid Structures 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Multiple Myeloma 1 Mesothelioma 1 Melanoma 1

Interventions

pembrolizumab 119 Cisplatin 70 Cetuximab 52 Carboplatin 46 Nivolumab 39 Paclitaxel 38 Docetaxel 33 Radiotherapy 32 Radiotherapy, Intensity-Modulated 23 Fluorouracil 19 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Taxes 11 durvalumab 10 cemiplimab 10 Radiation 10 Platinum 10 Ipilimumab 10 1,2-diaminocyclohexaneplatinum II citrate 10 atezolizumab 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Surgical Procedures, Operative 7 Standard of Care 7 Chemoradiotherapy 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 avelumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡